Padron, E., Painter, J. S., Kunigal, S., Mailloux, A. W., McGraw, K., McDaniel, J. M., . . . Epling-Burnette, P. K. (2013). GM-CSF–dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia. Blood.
Citación estilo ChicagoPadron, Eric, et al. "GM-CSF–dependent PSTAT5 Sensitivity Is a Feature With Therapeutic Potential in Chronic Myelomonocytic Leukemia." Blood 2013.
Cita MLAPadron, Eric, et al. "GM-CSF–dependent PSTAT5 Sensitivity Is a Feature With Therapeutic Potential in Chronic Myelomonocytic Leukemia." Blood 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.